Fort Point Capital Partners LLC Novo Cure LTD Transaction History

Fort Point Capital Partners LLC

  • $749 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $150,235 - $244,101
-2,001 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$116.17 - $194.55 $11,500 - $19,260
-99 Reduced 4.71%
2,001 $232,000
Q2 2021

Jul 30, 2021
SELL
$130.4 - $225.58 $43,032 - $74,441
-330 Reduced 13.58%
2,100 $466,000
Q3 2020

Nov 10, 2020
BUY
$58.05 - $111.31 $141,061 - $270,483
2,430 New
2,430 $270,000

Others Institutions Holding NVCR

# of Institutions
277
Shares Held
73.2M
Call Options Held
1.43M
Put Options Held
832K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.8B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email